These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25636063)

  • 21. Multigenic modeling of complex disease by random forests.
    Sun YV
    Adv Genet; 2010; 72():73-99. PubMed ID: 21029849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Planning a genome-wide association study: points to consider.
    Hakonarson H; Grant SF
    Ann Med; 2011; 43(6):451-60. PubMed ID: 21595511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease.
    Blue GM; Kirk EP; Giannoulatou E; Dunwoodie SL; Ho JW; Hilton DC; White SM; Sholler GF; Harvey RP; Winlaw DS
    J Am Coll Cardiol; 2014 Dec; 64(23):2498-506. PubMed ID: 25500235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new expectation-maximization statistical test for case-control association studies considering rare variants obtained by high-throughput sequencing.
    Gordon D; Finch SJ; De La Vega FM
    Hum Hered; 2011; 71(2):113-25. PubMed ID: 21734402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimum designs for next-generation sequencing to discover rare variants for common complex disease.
    Shi G; Rao DC
    Genet Epidemiol; 2011 Sep; 35(6):572-9. PubMed ID: 21618604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the genetic determinants of hemostasis and thrombosis.
    Desch KC
    Curr Opin Hematol; 2015 Sep; 22(5):428-36. PubMed ID: 26248003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical applications of molecular genetic discoveries.
    Marian AJ
    Transl Res; 2016 Feb; 168():6-14. PubMed ID: 26548329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From lipid locus to drug target through human genomics.
    van der Laan SW; Harshfield EL; Hemerich D; Stacey D; Wood AM; Asselbergs FW
    Cardiovasc Res; 2018 Jul; 114(9):1258-1270. PubMed ID: 29800275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of Insulin Resistance and the Metabolic Syndrome.
    Brown AE; Walker M
    Curr Cardiol Rep; 2016 Aug; 18(8):75. PubMed ID: 27312935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-generation sequencing of nine atrial fibrillation candidate genes identified novel de novo mutations in patients with extreme trait of atrial fibrillation.
    Tsai CT; Hsieh CS; Chang SN; Chuang EY; Juang JM; Lin LY; Lai LP; Hwang JJ; Chiang FT; Lin JL
    J Med Genet; 2015 Jan; 52(1):28-36. PubMed ID: 25391453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based association and gene by environment interactions in Genetic Analysis Workshop 18.
    Satten GA; Biswas S; Papachristou C; Turkmen A; König IR
    Genet Epidemiol; 2014 Sep; 38 Suppl 1():S49-56. PubMed ID: 25112188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic susceptibility to cerebrovascular disease.
    Della-Morte D; Pacifici F; Rundek T
    Curr Opin Lipidol; 2016 Apr; 27(2):187-95. PubMed ID: 26959706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polygenic influences on dyslipidemias.
    Dron JS; Hegele RA
    Curr Opin Lipidol; 2018 Apr; 29(2):133-143. PubMed ID: 29300201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias.
    Johansen CT; Dubé JB; Loyzer MN; MacDonald A; Carter DE; McIntyre AD; Cao H; Wang J; Robinson JF; Hegele RA
    J Lipid Res; 2014 Apr; 55(4):765-72. PubMed ID: 24503134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining genome-wide data from humans and animal models of dyslipidemia and atherosclerosis.
    Berisha SZ; Smith JD
    Curr Opin Lipidol; 2011 Apr; 22(2):100-5. PubMed ID: 21178769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome: genetic insights into disease pathogenesis.
    Abou Ziki MD; Mani A
    Curr Opin Lipidol; 2016 Apr; 27(2):162-71. PubMed ID: 26825138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting X-linked common and rare variant effects in family-based sequencing studies.
    Turkmen AS; Lin S
    Genet Epidemiol; 2021 Feb; 45(1):36-45. PubMed ID: 32864779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. U-statistics in genetic association studies.
    Li H
    Hum Genet; 2012 Sep; 131(9):1395-401. PubMed ID: 22610525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Less common variants association study and statistical analysis].
    Liao X; Deng J; Xun JY; Yan JX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):977-982. PubMed ID: 28738478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics-driven discovery of novel regulators of lipid metabolism.
    Ha EE; Van Camp AG; Bauer RC
    Curr Opin Lipidol; 2019 Jun; 30(3):157-164. PubMed ID: 30985365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.